Response to PARP Inhibitor Predicted by the RAD51 Assay
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
- Status
- WITHDRAWN
- Phase
- N/A
MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class
- Status
- COMPLETED
- Phase
- PHASE1
Simplifying Survivorship Care Planning
- Status
- COMPLETED
- Phase
- NA
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
- Status
- WITHDRAWN
- Phase
- PHASE2
Treatment Algorithm for Nausea and Vomiting in the Palliative Phase
- Status
- UNKNOWN
- Phase
- PHASE4
A Stepped Wedge Cluster Randomized Controlled Trial to Assess a Strategy Aiming to Optimize Psychosocial Outcomes in Patients With Cancer
- Status
- COMPLETED
- Phase
- NA
The Sakakibara Health Integrative Profile Cohort Study
- Status
- COMPLETED
- Phase
- N/A
The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study
- Status
- RECRUITING
- Phase
- N/A
Health Literacy Multi-media Study
- Status
- COMPLETED
- Phase
- NA
Patient Experience and Acceptance of Horizontal Rotation
- Status
- TERMINATED
- Phase
- NA
Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials
- Status
- UNKNOWN
- Phase
- N/A
The Copenhagen City Heart Study
- Status
- COMPLETED
- Phase
- N/A
FOCUS:Families OverComing Under Stress
- Status
- COMPLETED
- Phase
- NA
Cancer Distress Coach Mobile App Trial
- Status
- COMPLETED
- Phase
- NA
A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Short Term Genetic Effects of Chemotherapy on Male Germ Cells
- Status
- COMPLETED
- Phase
- N/A
Improving Symptom Self-management in Adolescents & Young Adults With Cancer
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
- Status
- TERMINATED
- Phase
- PHASE1